IP Library › Assignment 066403/0804
Patent Assignment
Reel/Frame 066403/0804

Assignment of Assignor's Interest

Recorded: 2024-01-31 Pages: 10
Assignor
OCERA THERAPEUTICS, INC.
Executed: 2024-01-30
Assignee
OCERA THERAPEUTICS LLC
675 MCDONNELL BLVD., HAZELWOOD, MISSOURI, 63042
Covered Properties (47)
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Methods of Making L-Ornithine Phenyl Acetate
Formulations of L-Ornithine Phenylacetate
Treatment and Prevention of Muscle Loss Using L-Ornithine in Combination with Atleast One of Phenylacetate and Phenylbu-Tyrate
Treatment and Prevention of Neuronal Cell Loss Using L-Ornithine in Combination with at Least One of Phenylacetate and Phenylbutyrate
Formulation of L-Ornithine Phenylacetate
Processes of Making L-Ornithine Phenylacetate
Methods of Assessing and Treating Hepatic Encephalopathy
Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Uses of Ornithine Phenylacetate for Treating Hyperammonemia
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 8,173,706 →
Application: 12/753,763 →
Publication: US 2010/0280119
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 8,492,439 →
Application: 13/436,642 →
Publication: US 2012/0208885
Methods of Making L-Ornithine Phenyl Acetate
Patent: 8,946,473 →
Application: 13/878,146 →
Publication: US 2013/0211135
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 8,785,498 →
Application: 13/937,107 →
Publication: US 2013/0296429
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 9,034,925 →
Application: 14/299,940 →
Publication: US 2014/0288327
Methods of Making L-Ornithine Phenyl Acetate
Patent: 9,260,379 →
Application: 14/601,591 →
Publication: US 2015/0133684
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Patent: 9,604,909 →
Application: 14/715,481 →
Publication: US 2015/0251990
Formulations of L-Ornithine Phenylacetate
Application: 15/133,087 →
Publication: US 2016/0338982
Formulations of L-Ornithine Phenylacetate
Application: 15/349,910 →
Publication: US 2017/0135973
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Application: 15/469,359 →
Publication: US 2018/0044281
Treatment and Prevention of Muscle Loss Using L-Ornithine in Combination with at Least One of Phenylacetate and Phenylbutyrate
Application: 15/750,009 →
Publication: US 2018/0221320
Treatment and Prevention of Neuronal Cell Loss Using L-Ornithine in Combination with at Least One of Phenylacetate and Phenylbutyrate
Application: 15/751,442 →
Publication: US 2020/0206174
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Application: 16/037,655 →
Publication: US 2018/0319736
Processes of Making L-Ornithine Phenylacetate
Application: 16/611,193 →
Publication: US 2020/0157033
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Application: 16/778,696 →
Publication: US 2020/0239406
L-Ornithine Phenyl Acetate and Methods of Making Thereof
Application: 17/516,591 →
Publication: US 2022/0162155
Formulations of L-Ornithine Phenylacetate
Application: 17/559,453 →
Publication: US 2022/0184014
Formulations of L-Ornithine Phenylacetate
Application: 17/570,253 →
Publication: US 2022/0202755
Methods of Assessing Hepatic Encephalopathy
Application: 17/605,699 →
Publication: US 2022/0249010
Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application: 17/767,009 →
Publication: US 2022/0362192
Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application: 17/926,978 →
Publication: US 2023/0201148
L-Orthnine Phenyl Acetate and Methods of Making Thereof
Application: 61/166,676 →
Methods of Making L-Ornithine Phenyl Acetate
Application: 61/390,585 →
Oral Formulations of L-Ornithine Phenylacetate
Application: 62/150,238 →
Oral Formulations of L-Ornithine Phenylacetate
Application: 62/150,676 →
Treatment and Prevention of Muscle Loss Using L-Ornithine Phenylacetate
Application: 62/206,466 →
Oral Formulations of L-Ornithine Phenylacetate
Application: 62/211,619 →
Treatment and Prevention of Neuronal Cell Loss Using L-Ornithine Phenylacetate
Application: 62/233,002 →
Oral Formulations of L-Ornithine Phenylacetate
Application: 62/255,300 →
Oral Formulations of L-Ornithine Phenylacetate
Application: 62/276,754 →
Processes of Making L-Ornithine Phenylacetate
Application: 62/504,911 →
Methods of Assessing Hepatic Encephalopathy
Application: 62/845,569 →
Dosages of L-Ornithine Phenylacetate for Treating Hyperammonemia
Application: 62/916,159 →
Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application: 62/965,330 →
Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application: 62/979,197 →
Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application: 63/028,874 →
Dosages and Uses of Ornithine Phenylacetate for Treating Hyperammonemia
Application: 63/034,602 →
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 12, 2017
From: HELSINN ADVANCED SYNTHESIS SA
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041349/0531 →
Assignment of Assignor's Interest Jan 12, 2017
From: DOUGAN, CHRISTINE HENDERSON; WATT, STEPHEN WILLIAM
To: SOLID FORM SOLUTIONS LTD.
Reel/Frame 040955/0956 →
Assignment of Assignor's Interest Jan 12, 2017
From: MANINI, PETER; FIGINI, ATTILIA
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 040955/0486 →
Assignment of Assignor's Interest Jan 12, 2017
From: SOLID FORM SOLUTIONS LTD.
To: OCERA THERAPEUTICS, INC.
Reel/Frame 040956/0024 →
Assignment of Assignor's Interest Jan 12, 2017
From: ANDERSON, KEITH; BEHLING, JIM; DOUGAN, CHRISTINE HENDERSON; WATT, STEPHEN WILLIAM
To: OCERA THERAPEUTICS, INC.
Reel/Frame 040960/0233 →
Assignment of Assignor's Interest Jan 26, 2017
From: MANINI, PETER; FIGINI, ATTILIA
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 041097/0984 →
Assignment of Assignor's Interest Jan 26, 2017
From: HELSINN ADVANCED SYNTHESIS SA
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041098/0001 →
Assignment of Assignor's Interest Jan 26, 2017
From: ANDERSON, KEITH; BEHLING, JIM
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041098/0038 →
Assignment of Assignor's Interest Jan 26, 2017
From: WATT, STEPHEN WILLIAM
To: SOLID FORM SOLUTIONS LTD.
Reel/Frame 041098/0043 →
Assignment of Assignor's Interest Jan 26, 2017
From: SOLID FORM SOLUTIONS LTD.
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041098/0073 →
Terms and Conditions of Employment Jan 26, 2017
From: DOUGAN, CHRISTINE
To: SOLID FORM SOLUTIONS LIMITED
Reel/Frame 041513/0173 →
Assignment of Assignor's Interest Feb 1, 2017
From: ROSE, CHRISTOPHER F.; CLÉMENT, MARC-ANDRÉ; BOSOI, CRISTINA R.; OLIVEIRA, MARIANA MACEDO
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041145/0903 →
Assignment of Assignor's Interest Feb 1, 2017
From: ROSE, CHRISTOPHER F.
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041145/0246 →
Assignment of Assignor's Interest Feb 1, 2017
From: ROUSSEAU, FRANCK
To: OCERA THERAPEUTICS, INC.
Reel/Frame 041145/0931 →
Notice of Grant of Security Interest in Intellectual Property Dec 22, 2017
From: OCERA THERAPEUTICS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 044949/0634 →
Assignment of Assignor's Interest May 15, 2018
From: ROSE, CHRISTOPHER F.; ROUSSEAU, FRANCK
To: OCERA THERAPEUTICS, INC.
Reel/Frame 045813/0066 →
Notice of Grant of Security Interest in Intellectual Property Jul 22, 2019
From: OCERA THERAPEUTICS
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 049823/0220 →
Assignment of Assignor's Interest Sep 20, 2019
From: WATT, STEPHEN WILLIAM; DOUGAN, CHRISTINE HENDERSON
To: SOLID FORM SOLUTIONS LTD.
Reel/Frame 050449/0015 →
Assignment of Assignor's Interest Sep 20, 2019
From: MANINI, PETER; FIGINI, ATTILIA
To: HELSINN ADVANCED SYNTHESIS SA
Reel/Frame 050449/0049 →
Assignment of Assignor's Interest Sep 20, 2019
From: HELSINN ADVANCED SYNTHESIS SA
To: OCERA THERAPEUTICS, INC. C/O MALLINCKRODT PHARMACEUTICALS
Reel/Frame 050452/0709 →
Assignment of Assignor's Interest Sep 23, 2019
From: ANDERSON, KEITH; BEHLING, JIM
To: OCERA THERAPEUTICS, INC. C/O MALLINCKRODT PHARMACEUTICALS
Reel/Frame 050455/0270 →
Assignment of Assignor's Interest Sep 23, 2019
From: SOLID FORM SOLUTIONS LTD.
To: OCERA THERAPEUTICS, INC. C/O MALLINCKRODT PHARMACEUTICALS
Reel/Frame 050455/0320 →
Notice of Grant of Security Interest in Intellectual Property Dec 9, 2019
From: MALLINCKRODT LLC; OCERA THERAPEUTICS, INC.; MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED
To: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
Reel/Frame 051231/0961 →
Security Interest Dec 10, 2019
From: MALLINCKRODT ARD IP LIMITED; MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED; SPECGX LLC; OCERA THERAPEUTICS, INC.
To: WILMINGTON SAVINGS FUND SOCIETY, FSB, AS SECOND LIEN COLLATERAL AGENT
Reel/Frame 051256/0829 →
Assignment of Assignor's Interest Mar 26, 2021
From: ROSE, CHRISTOPHER F.; CLÉMENT, MARC-ANDRÉ; BOSOI, CRISTINA R.; OLIVEIRA, MARIANA MACEDO
To: OCERA THERAPEUTICS, INC.
Reel/Frame 055733/0984 →